American Journal of Respiratory Cell and Molecular Biology. Vol. 27, pp. 487-494, 2002
© 2002 American Thoracic Society DOI: 10.1165/rcmb.4818
Phosphodiesterase 4 Inhibitor Cilomilast Inhibits Fibroblast-Mediated Collagen Gel Degradation Induced by Tumor Necrosis Factor- and Neutrophil Elastase
Tadashi Kohyama,
Xiangde Liu,
Yun Kui Zhu,
Fu-Qiang Wen,
Hang Jun Wang,
Qiuhong Fang,
Tetsu Kobayashi and
Stephen I. Rennard
Department of Respiratory Medicine, University of Tokyo, Tokyo, Japan; University of Nebraska Medical Center, Omaha, Nebraska; Department of Respiratory Diseases, Jincheng Hospital, Lanzhou, China; and Mount Sinai Hospital, Toronto, Ontario, Canada
Address correspondence to: Stephen I. Rennard, M.D., Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, 985125 Nebraska Medical Center, Omaha, NE 68198-5125. E-mail: srennard{at}unmc.edu
Tissue destruction, resulting in emphysema, can be a consequence of several pathologic processes. The current study evaluated the effects of the phosphodiesterase (PDE)4 inhibitor, cilomilast, and other PDE inhibitors on the ability of fibroblasts to degrade extracellular matrix. Using the three-dimensional collagen gel culture system, fibroblasts (HFL-1) were cultured with tumor necrosis factor (TNF)- , known to induce matrix metalloproteinase (MMP) release, and/or neutrophil elastase (NE), which can induce MMP activation. On Day 4, gels containing TNF- and NE were significantly degraded (20.8 ± 2.9% of original collagen content). Cilomilast (10 µM) inhibited this degradation (84.4 ± 8.4%). Amrinone, a PDE3 inhibitor, and zaprinast, a PDE5 inhibitor, had no effect. Gelatin zymography and immunoblotting revealed that fibroblasts cultured with TNF- released increased amounts of latent MMP-1 and -9. The addition of NE resulted in the conversion of MMP-1 and -9 to their active forms, indicative of collagen degradation. Cilomilast inhibited the release of MMP-1 and -9, as well as conversion of MMP-1 to its active form. Using real-time PCR analysis, cilomilast's effect on MMP-1 release was not associated with the proteinase's mRNA expression, suggesting that the inhibition of release is regulated at the post-transcriptional level. These results suggest that cilomilast may be a potentially effective therapeutic agent in diseases characterized by excessive tissue destruction, such as emphysema.
Abbreviations: Dulbecco's modified Eagle's medium, DMEM extracellular matrix, ECM enzyme-linked immunosorbent assay, ELISA fetal calf serum, FCS human fetal lung fibroblasts, HFL-1 horseradish peroxidase, HRP matrix metalloprotease, MMP neutrophil elastase, NE polyacrylamide gel electrophoresis, PAGE phosphate-buffered saline, PBS polymerase chain reaction, PCR phosphodiesterase, PDE reverse transcription, RT rat tail tendon collagen, RTTC sodium dodecyl sulfate, SDS tissue inhibitor of metalloprotease, TIMP tumor necrosis factor- , TNF-
This article has been cited by other articles:

|
 |

|
 |
 
S. Togo, X. Liu, X. Wang, H. Sugiura, K. Kamio, S. Kawasaki, T. Kobayashi, R. F. Ertl, Y. Ahn, O. Holz, et al.
PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts
Am J Physiol Lung Cell Mol Physiol,
June 1, 2009;
296(6):
L959 - L969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Martorana, R. Beume, M. Lucattelli, L. Wollin, and G. Lungarella
Roflumilast Fully Prevents Emphysema in Mice Chronically Exposed to Cigarette Smoke
Am. J. Respir. Crit. Care Med.,
October 1, 2005;
172(7):
848 - 853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Oger, C. Mehats, E. Dallot, D. Cabrol, and M.-J. Leroy
Evidence for a Role of Phosphodiesterase 4 in Lipopolysaccharide-Stimulated Prostaglandin E2 Production and Matrix Metalloproteinase-9 Activity in Human Amniochorionic Membranes
J. Immunol.,
June 15, 2005;
174(12):
8082 - 8089.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society.
|
|
|